Stayble Therapeutics AB (publ) (STABL.ST)
SEK 0.39
(1.56%)
SEK 0.39
(1.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -23.53 Million | -24.88 Million | -9.63 Million | -23.98 Million | 289.39 Thousand | -5.42 Million |
| Net Income | -23.73 Million | -24.52 Million | -12.09 Million | -15.48 Million | -7.4 Million | -6.13 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 7155.00 | -95.02 Thousand | 2.53 Million | -8.66 Million | 7.69 Million | 712 Thousand |
| Other non-cash items | 192.98 Thousand | -264.83 Thousand | -77.59 Thousand | 166.17 Thousand | -7.72 Million | -712 Thousand |
| Investing Cash Flow | - | 1000.00 | -1000.00 | - | - | 1000.00 |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -1000.00 | - | - | - |
| Sales/Maturities of investments | - | 1000.00 | - | - | - | 1000.00 |
| Other Investing Activities | - | - | -1.00 | - | - | 1000.00 |
| Financing Cash Flow | 24.96 Million | 1.00 | 36.15 Million | 31.19 Million | 500 Thousand | 5 Million |
| Debt repayment | - | -1.00 | -194.44 Thousand | -138.88 Thousand | -500 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 24.96 Million | - | 36.34 Million | 35.14 Million | - | 5 Million |
| Other Financing Activities | 24.96 Million | - | 36.34 Million | -3.81 Million | 1 Million | 5 Million |
| Accounts receivables | -1.32 Million | -129.5 Thousand | 957.73 Thousand | -1.23 Million | 85.14 Thousand | 33.4 Thousand |
| Accounts payables | 1.32 Million | 34.47 Thousand | 1.57 Million | -7.42 Million | 7.62 Million | 678.6 Thousand |
| Inventory | - | -34.48 | -1577.69 | 7427.44 | - | - |
| Other working capital | 1.32 Million | 34.48 | 1577.69 | -7427.44 | -11.28 Thousand | 678.55 Thousand |
| Cash at beginning of period | 12.84 Million | 37.46 Million | 10.86 Million | 3.82 Million | 3.03 Million | 3.45 Million |
| Cash at end of period | 14.07 Million | 12.84 Million | 37.46 Million | 10.86 Million | 3.82 Million | 3.03 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | -192.98 Thousand | 264.83 Thousand | 77.59 Thousand | -166.17 Thousand | - | - |
| Net cash flow / Change in cash | 1.23 Million | -24.61 Million | 26.59 Million | 7.04 Million | 789.39 Thousand | -420.8 Thousand |
| Free Cash Flow | -23.53 Million | -24.88 Million | -9.63 Million | -23.98 Million | 289.39 Thousand | -5.42 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.43 Million | -3.63 Million | -6.28 Million | -23.73 Million | -7.04 Million | -6.66 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 1.84 Million | -3.58 Million | -925.84 Thousand | 7155.00 | 2.73 Million | 730 Thousand |
| Other non-cash items | -1.84 Million | 3.58 Million | 1.11 Million | 185.83 Thousand | -2.73 Million | -730 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 2.78 Million | - | 225.00 | 24.96 Million | - | 25.33 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -0.32 | - | - | - |
| Common Stock Issuance | 2.78 Million | - | 225.00 | 24.96 Million | - | 31.81 Million |
| Other Financing Activities | 2782.00 | - | 0.54 | 24.96 Million | - | -6.48 Million |
| Accounts receivables | 143 Thousand | -242 Thousand | 211.1 Thousand | -1.32 Million | 595 Thousand | 1.52 Million |
| Accounts payables | 1.7 Million | -3.34 Million | -1.13 Million | 1.32 Million | 2.13 Million | -797 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1705.00 | -3341.00 | -1136.95 | 1.32 Million | 2138.00 | -798.00 |
| Cash at beginning of period | 6.86 Million | 14.07 Million | 21.29 Million | 12.84 Million | 25.6 Million | 6.2 Million |
| Cash at end of period | 8.05 Million | 6.86 Million | 14.07 Million | 14.07 Million | 21.29 Million | 25.6 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | -192.99 | -192.98 Thousand | - | - |
| Net cash flow / Change in cash | 1.19 Million | -7.21 Million | -7.21 Million | 1.23 Million | -4.31 Million | 19.4 Million |
| Free Cash Flow | -1.58 Million | -7.21 Million | -7.02 Million | -23.53 Million | -4.31 Million | -5.93 Million |
KWG
AV
NURI
BLX
9890
AMJLAND